Smartphone-Integrated Consumer Pulse Oximetry Baby Monitors May Not Be Accurate

Compared with an FDA-approved monitor, two non–FDA-approved monitors had inaccurate and inconsistent readings.

As smartphone-integrated health apps become more ubiquitous, the accuracy of those that are not FDA approved is of concern. Researchers compared oximetry and pulse rate readings between two commercially available but not FDA approved home monitor devices (A: Owlet Smart Sock 2 and B: Baby Vida) and an FDA-approved oximetry device (Masimo Radical-7) in 30 hospitalized noncritically ill patients aged 0–6 months (median age, 50 days).

Each patient had the FDA-approved monitor attached to one foot and the other two monitors attached to the other foot alternately in random order. Exclusion criteria included prematurity (<34 weeks' gestation), anemia, fever, hypothermia, and hypotension.

A total of 2266 simultaneous SpO₂ and 1801 simultaneous pulse…

Reviewing Author

F. Bruder Stapleton, MD

Disclosures

Consultant/Advisory BoardCareer Physician

Editorial BoardsUpToDate

Leadership Positions in Professional SocietiesAmerican Society of Pediatric Nephrology Foundation (Chair)

F. Bruder Stapleton, MD

Disclosures

Consultant/Advisory BoardCareer Physician

Editorial BoardsUpToDate

Leadership Positions in Professional SocietiesAmerican Society of Pediatric Nephrology Foundation (Chair)

Smartphone-Integrated Consumer Pulse Oximetry Baby Monitors May Not Be Accurate

Topics

Reviewing Author